FDA NEWS

Bristol-Myers, AstraZeneca Diabetes Drug Effective In Study - CNN Money
NEW YORK -(Dow Jones)- A late-stage study of saxagliptin, developed by Bristol-Myers Squibb Co. (BMY) and AstraZeneca (AZN), shows the drug is effective in treating type 2 diabetes with a safety profile similar to placebo. The companies also proposed
Source: money.cnn.com

Fidelity's top lawyer resigns to be full-time law teacher - Boston Globe
FDA adds cancer warning to J&J foot ulcer medicine The Food and Drug Administration warned patients that using large amounts of a Johnson & Johnson foot ulcer medication could heighten their risk of dying from cancer. The FDA added its most serious
Source: www.boston.com

ADA Comments on FDA's Settlement of Dental Amalgam Lawsuit - Biloxi Sun Herald
The American Dental Association (ADA) believes the recent settlement between the U.S. Food and Drug Administration (FDA) and the group Moms Against Mercury simply sets a definite deadline (July 28, 2009) for the FDA to complete what it began in 2002
Source: www.sunherald.com

Bristol, Takeda Drugs Offer Alternatives to Januvia (Correct) - Bloomberg
June 7 (Bloomberg) -- Bristol-Myers Squibb Co ., AstraZeneca Plc and Takeda Pharmaceuticals Co. 's experimental diabetes drugs may give U.S. patients effective alternatives to Merck & Co.'s Januvia, one of the newest pills approved for the condition
Source: www.bloomberg.com